Back to Search Start Over

Multi-target assessment of advanced oxidation processes-based strategies for indirect potable reuse of tertiary wastewater: Fate of compounds of emerging concerns, microbial and ecotoxicological parameters.

Authors :
Murgolo S
De Giglio O
De Ceglie C
Triggiano F
Apollonio F
Calia C
Pousis C
Marzella A
Fasano F
Giordano ME
Lionetto MG
Santoro D
Santoro O
Mancini S
Di Iaconi C
De Sanctis M
Montagna MT
Mascolo G
Source :
Environmental research [Environ Res] 2024 Jan 15; Vol. 241, pp. 117661. Date of Electronic Publication: 2023 Nov 19.
Publication Year :
2024

Abstract

Two advanced oxidation processes (AOPs), namely ozone/H <subscript>2</subscript> O <subscript>2</subscript> and UV/H <subscript>2</subscript> O <subscript>2</subscript> , were tested at pilot scale as zero-liquid-discharge alternative treatments for the removal of microbiological (bacteria and viruses), chemical (compounds of emerging concern (CECs)) and genotoxic responses from tertiary municipal wastewater for indirect potable reuse (IPR). The AOP treated effluents were further subjected to granular activated carbon (GAC) adsorption and UV disinfection, following the concept of multiple treatment barriers. As a reference, a consolidated advanced wastewater treatment train consisting of ultrafiltration, UV disinfection, and reverse osmosis (RO) was also employed. The results showed that, for the same electrical energy applied, the ozone/H <subscript>2</subscript> O <subscript>2</subscript> treatment was more effective than the UV/H <subscript>2</subscript> O <subscript>2</subscript> treatment in removing CECs. Specifically, the ozone/H <subscript>2</subscript> O <subscript>2</subscript> treatment, intensified by high pressure and high mixing, achieved an average CECs removal efficiency higher than UV/H <subscript>2</subscript> O <subscript>2</subscript> (66.8% with respect to 18.4%). The subsequent GAC adsorption step, applied downstream the AOPs, further improved the removal efficiency of the whole treatment trains, achieving rates of 98.5% and 96.8% for the ozone/H <subscript>2</subscript> O <subscript>2</subscript> and UV/H <subscript>2</subscript> O <subscript>2</subscript> treatments, respectively. In contrast, the ultrafiltration step of the reference treatment train only achieved a removal percentage of 22.5%, which increased to 99% when reverse osmosis was used as the final step. Microbiological investigations showed that all three wastewater treatment lines displayed good performance in the complete removal of regulated and optional parameters according to both national and the European Directive 2020/2184. Only P. aeruginosa resulted resistant to all treatments with a higher removal by UV/H <subscript>2</subscript> O <subscript>2</subscript> when higher UV dose was applied. In addition, E. coli STEC/VTEC and enteric viruses, were found to be completely removed in all tested treatments and no genotoxic activity was detected even after a 1000-fold concentration. The obtained results suggest that the investigated treatments are suitable for groundwater recharge to be used as a potable water source being such a procedure an IPR. The intensified ozone/H <subscript>2</subscript> O <subscript>2</subscript> or UV/H <subscript>2</subscript> O <subscript>2</subscript> treatments can be conveniently incorporated into a multi-barrier zero-liquid-discharge scheme, thus avoiding the management issues associated with the retentate of the conventional scheme that uses reverse osmosis. By including the chemical cost associated with using 11-12 mg/L of H <subscript>2</subscript> O <subscript>2</subscript> in the cost calculations, the overall operational cost (energy plus chemical) required to achieve 50% average CECs removal in tertiary effluent for an hypothetical full-scale plant of 250 m <superscript>3</superscript> /h (or 25,000 inhabitants) was 0.183 €/m <superscript>3</superscript> and 0.425 €/m <superscript>3</superscript> for ozone/H <subscript>2</subscript> O <subscript>2</subscript> and UV/H <subscript>2</subscript> O <subscript>2</subscript> treatment train, respectively.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1096-0953
Volume :
241
Database :
MEDLINE
Journal :
Environmental research
Publication Type :
Academic Journal
Accession number :
37980992
Full Text :
https://doi.org/10.1016/j.envres.2023.117661